Volume 6; Issue 4

Main
Pharmacogenetics
Volume 6; Issue 4

Pharmacogenetics

Volume 6; Issue 4

1

Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms

Krynetski, Eugene Y., Tai, Hung-Liang, Yates, Charles R., Fessing, Michael Y., Loennechen, Thrina, Schuetz, John D., Relling, Mary V., Evans, William E.

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 1009 KB

1996

2

The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism

Sullivan-Klose, Theresa H., Ghanayem, Burhan I., Bell, Douglas A., Zhang, Zhi-Yi, Kaminsky, Laurence S., Shenfleld, Gillian M., Miners, John O., Birkett, Donald J., Goldstein, Joyce A.

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 862 KB

1996

3

Polymorphism in the human O6-methylguanine-DNA methyltransferase gene detected by PCR-SSCP analysis

Otsuka, M, Abe, M, Nakabeppu, Y, Sekiguchi, M, Suzuki, T

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 228 KB

1996

4

Promoter region analysis of the rat CYP2B1 and CYP2B2 genes

Sommer, Karen M., Ramsden, Richard, Sidhu, Jaspreet, Costa, Paola, Omiecinski, Curtis J.

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 465 KB

1996

5

Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2

Buters, Jeroen T.M., Tang, Bing-Kou, Pineau, Thierry, Gelboin, Harry V., Kimura, Shioko, Gonzalez, Frank J.

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 470 KB

1996

6

Exon and intron variants in the human tryptophan 2,3-dioxygenase gene: potential association with Tourette syndrome, substance abuse and other disorders

Comings, David E., Gade, Radhika, Muhleman, Donn, Chiu, Connie, Wu, Shijuan, To, Michael, Spence, Matthew, Dietz, George, Winn-Deen, Emily, Rosenthal, Richard J., Lesieur, Henry R., Rugle, Loreen, Sve

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 960 KB

1996

7

PCR-based genotyping for duplicated and deleted CYP2D6 genes

Johansson, Inger, Lundqvist, Eva, Dahl, Marja-Liisa, Ingelman-Sundberg, Magnus

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 316 KB

1996

8

Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype??

Daly, Ann K., Idle, Jeffrey R., Fairbrother, Karen S., Andreassen, Ole A., London, Stephanie J., Steen, Vidar M.

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 771 KB

1996

9

Genetic polymorphism of S-mephenytoin 4??-hydroxylation in African-Americans

Edeki, Timi I., Goldstein, Joyce A., de Morais, Sonia M.F., Hajiloo, Leila, Butler, Marcela, Chapdelaine, Perry, Wilkinson, Grant R.

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 396 KB

1996

10

A retroviral element in the human CYP2D gene cluster

Molven, Anders, Steen, Vidar M.

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 245 KB

1996

11

Increased prevalence of the Taq I A1allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report

Blum, Kenneth, Braverman, Eric R., Wood, Robert C., Gill, James, Li, Christie, Chen, Thomas J.H., Taub, Mathew, Montgomery, Ann R., Sheridan, Peter J., Cull, John G.

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 842 KB

1996

12

CYP2C19 genotyping and associated mephenytoin hydroxylation polymorphism in a Canadian Inuit population

Jurima-Romet, Malle, Goldstein, Joyce A., LeBelle, Michael, Aubin, Remy A., Foster, Brian C., Walop, Wikke, Rode, Andris

Journal:

Pharmacogenetics

Year:

1996

File:

PDF, 894 KB

1996